AC T04952
XX
ID T04952
XX
DT 28.11.2001 (created); rge.
DT 01.02.2012 (updated); yre.
CO Copyright (C), QIAGEN.
XX
FA TEF-5
XX
SY DTEF-1; ETFR-1; RP1-109F14.4; TEA domain family member 3; TEAD-3; TEAD3; TEAD5; TEF-5; TEF5.
XX
OS human, Homo sapiens
OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates
XX
GE G005555 TEAD3; HGNC: TEAD3.
XX
CL C0024; TEA; 3.6.1.0.4.
XX
IN T06040 CtBP2; human, Homo sapiens.
IN T25956 YAP-isoform2; human, Homo sapiens.
IN T22876 YAP; human, Homo sapiens.
XX
MX M04144 V$TEAD3_02.
MX M04635 V$TEF5_Q2.
MX M08903 V$TEF5_Q6_01.
XX
BS R21267.
BS R21264.
XX
DR TRANSPATH: MO000028724.
DR UniProtKB: Q99594;
XX
RN [1]; RE0017317.
RX PUBMED: 9148898.
RA Jacquemin P., Martial J. A., Davidson I.
RT Human TEF-5 is preferentially expressed in placenta and binds to multiple functional elements of the human chorionic somatomammotropin-B gene enhancer
RL J. Biol. Chem. 272:12928-12937 (1997).
RN [2]; RE0071974.
RX PUBMED: 21909427.
RA Wang P., Bai Y., Song B., Wang Y., Liu D., Lai Y., Bi X., Yuan Z.
RT PP1A-mediated dephosphorylation positively regulates YAP2 activity.
RL PLoS ONE 6:e24288 (2011).
XX
//